(Q73153245)
Statements
Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group (English)
S Jones
C Vogel
A Arkhipov
L Fehrenbacher
P Eisenberg
B Cooper
S Honig
A Polli
F Whaley
E di Salle
J Tiffany
A Consonni